Loading...
XLON
BVC
Market cap100mUSD
Sep 17, Last price  
16.90GBP
1D
3.05%
1Q
3.05%
Jan 2017
-9.26%
Name

Batm Advanced Communications Ltd

Chart & Performance

D1W1MN
XLON:BVC chart
No data to show
P/E
P/S
0.86
EPS
Div Yield, %
Shrs. gr., 5y
0.56%
Rev. gr., 5y
-1.00%
Revenues
117m
-4.47%
56,514,00073,472,00096,952,000134,462,080135,394,355120,577,688127,633,570107,774,000114,155,000109,247,00097,096,00090,404,000107,137,000119,561,000123,396,000183,566,000140,038,000116,123,000122,830,000117,336,000
Net income
-22m
L+11,452.33%
-3,423,0006,445,00019,874,00024,204,66120,516,8441,698,7840713,000-4,513,000-3,176,000-13,250,000-1,070,000233,000585,0003,917,0009,793,00014,340,0001,556,000-193,000-22,296,000
CFO
-2m
L
-3,213,0003,776,00012,644,0009,093,33520,233,88612,481,7603,137,7273,206,000634,000-5,282,000-2,247,000915,00056,0002,607,0007,166,00018,459,0005,592,000-2,784,0005,009,000-1,653,000
Dividend
Dec 09, 20210.74 GBP/sh

Profile

BATM Advanced Communications Ltd., together with its subsidiaries, develops, produces, and markets real-time technologies in Israel, the United States, and Europe. It operates through two segments, Networking and Cyber, and Bio-Medical. The Networking and Cyber segment is involved in the research and development, production, and marketing of data communication products, including network function virtualization, edge computing, carrier ethernet and MPLS access solutions, cyber network monitoring, and network encryption. This segment also offers software services, such as training and technical support, laboratory service and maintenance; and construction contracts. The Bio-Medical segment offers molecular biology diagnostics; and solutions to treat pathogenic and medical waste in laboratories and hospitals, as well as for pharmaceutical manufacturing plants and agricultural applications. This segment also administers testing services; and distributes diagnostic equipment and medical supplies of various brands. The company was incorporated in 1992 and is headquartered in Hod Hasharon, Israel.
IPO date
Aug 12, 1996
Employees
949
Domiciled in
IL
Incorporated in
IL

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
117,336
-4.47%
122,830
5.78%
116,123
-17.08%
Cost of revenue
92,755
123,482
115,417
Unusual Expense (Income)
NOPBT
24,581
(652)
706
NOPBT Margin
20.95%
0.61%
Operating Taxes
1,728
839
339
Tax Rate
7.03%
48.02%
NOPAT
22,853
(1,491)
367
Net income
(22,296)
11,452.33%
(193)
-112.40%
1,556
-89.15%
Dividends
(4,300)
Dividend yield
3.55%
Proceeds from repurchase of equity
(1,325)
BB yield
1.09%
Debt
Debt current
6,293
5,106
4,219
Long-term debt
6,748
8,458
11,500
Deferred revenue
Other long-term liabilities
7,243
4,047
4,009
Net debt
(31,879)
(46,314)
(36,212)
Cash flow
Cash from operating activities
(1,653)
5,009
(2,784)
CAPEX
(700)
(2,404)
(4,468)
Cash from investing activities
(1,216)
(6,120)
(16,342)
Cash from financing activities
(2,612)
(2,160)
(7,050)
FCF
27,974
224
(13,347)
Balance
Cash
31,570
40,764
44,167
Long term investments
13,350
19,114
7,764
Excess cash
39,053
53,736
46,125
Stockholders' equity
(301,923)
(249,490)
(279,325)
Invested Capital
410,799
382,057
406,494
ROIC
5.76%
0.09%
ROCE
22.58%
0.55%
EV
Common stock shares outstanding
437,030
436,818
442,357
Price
0.18
-8.89%
0.20
-26.09%
0.27
-67.42%
Market cap
80,632
-8.84%
88,456
-27.02%
121,206
-67.56%
EV
47,672
71,099
116,740
EBITDA
29,549
4,524
5,597
EV/EBITDA
1.61
15.72
20.86
Interest
1,387
1,374
2,011
Interest/NOPBT
5.64%
284.84%